Abstract
Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) are the most highly expressed transcripts in all EBV-associated tumors and are involved in both lymphoid and epithelioid carcinogenesis. Our previous study on Chinese isolates from non-endemic area of nasopharyngeal carcinoma (NPC) identified new EBER variants (EB-8m and EB-10m) which were less common but relatively more frequent in NPC cases than healthy donors. In the present study, we determined the EBER variants in NPC cases and healthy donors from endemic and non-endemic areas of NPC within China and compared the EBER variants, in relation to the genotypes at BamHI F region (prototype F and f variant), between population groups and between two areas. According to the phylogenetic tree, four EBER variants (EB-6m, EB-8m, EB-10m and B95-8) were identified. EB-6m was dominant in all population groups except for endemic NPC group, in which EB-8m was dominant. EB-8m was more common in endemic NPC cases (82.0%, 41/50) than non-endemic NPC cases (33.7%, 32/95) (p<0.0001), and it was also more frequent in healthy donors from endemic area (32.4%, 24/74) than healthy donors from non-endemic area (1.1%, 1/92) (p<0.0001). More importantly, the EB-8m was more prevalent in NPC cases than healthy donors in both areas (p<0.0001). The f variant, which has been suggested to associate with endemic NPC, demonstrated preferential linkage with EB-8m in endemic isolates, however, the EB-8m variant seemed to be more specific to NPC isolates than f variant. These results reveal high prevalence of EBER EB-8m variant in endemic NPC cases, suggesting an association between NPC development and EBV isolates carrying EB-8m variant. Our finding identified a small healthy population group that shares the same viral strain which predominates in NPC cases. It could be interesting to carry extensive cohort studies following these individuals to evaluate the risk to develop NPC.
Highlights
Epstein-Barr virus (EBV) is a lymphotropic virus that infects more than 90% of the world's population and is associated with the development of both lymphoid and epithelial tumors, such as Burkitt's lymphoma (BL), Hodgkin's disease (HD), B- and T-cell lymphomas, nasopharyngeal carcinoma (NPC) and gastric carcinoma [1]
For cases in non-endemic area of NPC, we have determined the variations of EBER in 47 NPC biopsies and 57 throat washing (TW) samples of healthy donors in the previous study [36]
In a small subset of cases (17 cases), our previous study showed that most of NPC cases harbor the same EBV subtype in tumor biopsies and matched TW samples defined by multiple loci, including EBER, EBNA1, EBNA3C, and RFLP at the BamHI F fragment and BamHI W1/ I1boudary region [50]
Summary
Epstein-Barr virus (EBV) is a lymphotropic virus that infects more than 90% of the world's population and is associated with the development of both lymphoid and epithelial tumors, such as Burkitt's lymphoma (BL), Hodgkin's disease (HD), B- and T-cell lymphomas, nasopharyngeal carcinoma (NPC) and gastric carcinoma [1]. The virus homogeneously targets populations from all geographic areas, the incidence of the diseases it causes varies drastically It is well known NPC occurs with a remarkable geographic pattern and is endemic in southern China, Hong Kong, Taiwan and Southeast Asia [2, 3]. What causes these variations in disease incidence is unclear. Specific EBNA1 or LMP1 subtype ((V-val or China 1) showed preferential occurrence in NPC biopsies [13, 14] These observations support the notion of pathogenic strains with NPC. The geographical distribution of EBV variants and their precise association to diseases remain unresolved
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.